CIK 0001661998
- Non-accelerated filer
- Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473468154
- Phone
- +1 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $320,396
- in 6 filings
Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-01 | TZIANABOS ARTHUR President & CEO | Sale | −12,400 | $17.39 | $216K | 127,605 |
| 2019-10-01 | TZIANABOS ARTHUR President & CEO | Sale | −100 | $18.23 | $2K | 127,505 |
| 2019-10-01 | Seymour Albert Chief Scientific Officer | Sale | −9,200 | $17.38 | $160K | 181,850 |
| 2019-10-01 | Seymour Albert Chief Scientific Officer | Sale | −100 | $18.23 | $2K | 181,750 |
| 2019-09-05 | Kelly Timothy P | Sale | −1,166 | $19.94 | $23K | 0 |
| 2019-09-03 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion | +6,000 | $0.64 | $4K | 6,000 |
| 2019-09-03 | Smith W Bradford CFO, Treasurer & Secretary | Sale | −6,000 | $18.74 | $112K | 0 |
| 2019-09-03 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion · Employee Stock Option | −6,000 | 139,404 | ||
| 2019-09-03 | Seymour Albert Chief Scientific Officer | Sale | −9,300 | $18.74 | $174K | 191,050 |
| 2019-09-03 | TZIANABOS ARTHUR President & CEO | Sale | −12,500 | $18.75 | $234K | 140,005 |
| 2019-08-01 | Seymour Albert Chief Scientific Officer | Sale | −9,300 | $17.37 | $162K | 200,350 |
| 2019-08-01 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion | +6,000 | $0.64 | $4K | 6,000 |
| 2019-08-01 | Smith W Bradford CFO, Treasurer & Secretary | Sale | −6,000 | $17.37 | $104K | 0 |
| 2019-08-01 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion · Employee Stock Option | −6,000 | 145,404 | ||
| 2019-08-01 | TZIANABOS ARTHUR President & CEO | Sale | −12,500 | $17.37 | $217K | 152,505 |
| 2019-07-11 | REICIN ALISE Director | Grant or award · Option (Right to Buy) | +31,160 | 31,160 | ||
| 2019-07-09 | Rasty Siyamak Chief Operating Officer | Sale | −8,000 | $20.00 | $160K | 222,707 |
| 2019-07-01 | Seymour Albert Chief Scientific Officer | Sale | −9,200 | $18.98 | $175K | 209,750 |
| 2019-07-01 | Seymour Albert Chief Scientific Officer | Sale | −100 | $19.56 | $2K | 209,650 |
| 2019-07-01 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion | +6,000 | $0.64 | $4K | 6,000 |
Page 20 of 25 · 492 trades